In brief, 10 6 passaged-3 cells were placed in 5-ml tubes and added with 5 µl of each antibody and 5 µl of blocking buffer. The cells were incubated in the dark at 4°C for 20-25 min, washed with PBS supplemented with 1% FBS and centrifuged at 400 g for 2 min. The cell pellet was then suspended in 300-500 µl washing Paclitaxel supplier buffer and analyzed by flow cytometry (FACScalibur cytometer equipped with 488 nm argon lasers). In this study,

IGG2 and IGG1 were used as isotope control. WinMDI Inhibitors,research,lifescience,medical software was used to analyze the flow cytometric results. Multilineage Differentiation Since the golden criterion for the identification of a cell population as MSC is the differentiation assay, the isolated Inhibitors,research,lifescience,medical cells were examined to find whether or not

they were able to give rise to osteocytic and adipocytic cell lineages. For this purpose, a confluent culture of the passaged-3 cells was established and treated with either osteogenic medium consisting of DMEM supplemented with 50 mg/ml ascorbic 2-phosphate Inhibitors,research,lifescience,medical (Sigma, USA), 10 nM Dexamethasone (Sigma, USA), and 10 mM β glycerol phosphate (Sigma, USA) or adipogenic medium consisting of DMEM supplemented with 50 μg/ml ascorbic acid 3-phosphate, 100 nM Dexamethasone, and 50 μg/ml Indomethacin. The cultures were incubated at 37ºC and 5% CO2 for 3 weeks. At the end of this period, the cultures

were fixed and stained by either Alizarin Red for bone mineralized matrix or Oil Red for cytoplasmic lipid droplets. The differentiations were also checked by RT-PCR for the specific bone markers, including osteocalcin and Runx2, and adipose, including PPAR gamma Inhibitors,research,lifescience,medical (peroxisome proliferators-activated receptor gamma) and LPL (Lipoprotein lipase). RT-PCR Analysis Total RNA was isolated from the osteogenic and adipogenic cultures using Trizol (Invitrogen). The RNA sample Inhibitors,research,lifescience,medical was treated with 1 U/µl of RNase-free DNaseI (EN0521; Fermentas, Opelstrasse 9,Germany) per 1 µg of RNA in the presence mafosfamide of 40 U/µl ribonuclease inhibitor (“type”:”entrez-nucleotide”,”attrs”:”text”:”E00311″,”term_id”:”2168599″,”term_text”:”E00311″E00311; Fermentasm, Germany) and 10x reaction buffer with MgCl2 for 30 min at 37°C to eliminate residual DNA. DNaseI was inactivated by adding 1-2 µl of 25 mM EDTA and incubated at 65°C for 10 min. Standard RT reactions were performed with 2 μg total RNA using random hexamer as a primer and a RevertAidTM First Strand cDNA Synthesis Kit (Fermentas, Germany) according to the manufacturer’s instructions. For every reaction set, one RNA sample was prepared without RevertAid MMuLV Reverse Transcriptase (RT-reaction) in order to provide a negative control of the subsequent PCR.